Overview

ASP8825 - A Study to Investigate the Food Effect on the Pharmacokinetics of ASP8825

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effect of food on the pharmacokinetics and safety after administration of ASP8825 in healthy non-elderly adult male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Gabapentin